Trials / Completed
CompletedNCT00106405
An Evaluation of the Safety and Efficacy of Memantine in Patients With Acute Mania Associated With Bipolar I Disorder
A Pilot Evaluation of the Safety and Efficacy of Memantine in Patients With Acute Mania Associated With Bipolar I Disorder
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 35 (actual)
- Sponsor
- Forest Laboratories · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Bipolar disorder affects 2.4 million adults in the USA between the ages of 18-65 and has considerable economic impact on our society. Bipolar mania accounts for 1 in 7 psychiatric emergencies and is associated with significant morbidity and mortality. The purpose of the study is to evaluate the safety and efficacy of open-label memantine in the acute management of adults with bipolar I disorder hospitalized for mania.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Memantine HCl |
Timeline
- Start date
- 2005-02-01
- Primary completion
- 2005-11-01
- Completion
- 2005-11-01
- First posted
- 2005-03-25
- Last updated
- 2012-03-05
Locations
6 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00106405. Inclusion in this directory is not an endorsement.